MUSCLE METABOLISM IN TRACK ATHLETES, USING P-31 MAGNETIC-RESONANCE SPECTROSCOPY

被引:45
|
作者
MCCULLY, KK
VANDENBORNE, K
DEMEIRLEIR, K
POSNER, JD
LEIGH, JS
机构
[1] MED COLL PENN,DEPT MED,PHILADELPHIA,PA 19129
[2] FREE UNIV BRUSSELS,DEPT SPORTS MED,B-1050 BRUSSELS,BELGIUM
[3] UNIV PENN,DEPT RADIOL,PHILADELPHIA,PA 19104
关键词
EXERCISE RECOVERY; HUMAN; PHOSPHOCREATINE;
D O I
10.1139/y92-190
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We tested whether preferred running event in track athletes would correlate with the initial rate of phosphocreatine (PCr) resynthesis following submaximal exercise. PCr recovery was measured in the calf muscles of 16 male track athletes and 7 male control subjects following 5 min of repeated plantar flexion against resistance. P(i), PCr, and pH were measured using phosphorus magnetic resonance spectroscopy (P-31 MRS) with an 8-cm surface coil in a 1.8-T magnet. During exercise, work levels were gradually increased to deplete PCr to 50-60% of the initial value. No drop in pH was seen in any of the subjects during this exercise. The areas of the PCr peaks following exercise were fit to monoexponential curves. Two or three tests were performed on each subject and the results averaged. Athletes were divided into three groups based on their primary event: sprinters running 400 m or less, middle-distance athletes running 400- 1500 m, and long-distance athletes running farther than 1500 m. The maximal rates of PCr resynthesis (mmol . min-1 . kg-1 muscle weight) were 64.8 +/- 8.6, for long-distance runners; 41.4 +/- 11, for middle-distance runners; 32.0 +/- 7.0, for sprinters; and 38.6 +/- 10, for controls (mean +/- SE). The faster PCr recovery rates seen in long-distance runners compared with sprinters indicate greater oxidative capacity, which is consistent with the known differences between athletes in these events.
引用
收藏
页码:1353 / 1359
页数:7
相关论文
共 50 条
  • [21] NON INVASIVE ASSESSMENT OF HEPATIC FRUCTOSE METABOLISM IN HUMANS BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY (P-31 MRS)
    OBERHANSLI, R
    GALLOWAY, G
    TAYLOR, D
    RAJAGOPALAN, B
    RADDA, G
    CLINICAL SCIENCE, 1985, 68 : P48 - P48
  • [22] PLASTICITY OF CRANIOMANDIBULAR MUSCLE FUNCTION - P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF THE RABBIT MASSETER MUSCLE
    CHANG, C
    ALCANTARA, M
    DECRESPIGNY, AJ
    CHEW, W
    MCNEILL, C
    MILLER, AJ
    AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS, 1995, 108 (02) : 168 - 179
  • [23] MEASUREMENT OF PHOSPHORUS-METABOLISM IN HYPERTROPHIC CARDIOMYOPATHY BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    RAJAGOPALAN, B
    MCKENNA, WJ
    BLACKLEDGE, MJ
    RADDA, GK
    CIRCULATION, 1987, 76 (04) : 250 - 250
  • [25] P-31 NUCLEAR MAGNETIC-RESONANCE (P-31 NMR) SPECTROSCOPY IN PEDIATRIC NEUROMUSCULAR DISORDERS
    HARCKE, HT
    MARKS, HG
    HARTZELL, CR
    CHANCE, B
    WARNELL, RA
    JOURNAL OF NUCLEAR MEDICINE, 1983, 24 (05) : P47 - P47
  • [26] HIGH-RESOLUTION P-31 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY OF DISEASED MUSCLE
    GLONEK, T
    BARANY, M
    DOYLE, DD
    BIOPHYSICAL JOURNAL, 1981, 33 (02) : A202 - A202
  • [27] DETECTION OF MUSCLE DISORDERS IN SYSTEMIC SCLERODERMA AND CREST USING P-31 MAGNETIC-RESONANCE SPECTROSCOPY (MRS)
    ADAMSGANDHI, LB
    PARK, JH
    VITAL, TL
    HERNANZSCHULMAN, M
    KING, LE
    OLSEN, NJ
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 926 - 926
  • [28] ASSESSMENT OF RENAL VIABILITY BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY
    BRETAN, PN
    VIGNERON, DB
    JAMES, TL
    WILLIAMS, RD
    HRICAK, H
    JUENEMANN, KP
    YEN, TSB
    TANAGHO, EA
    JOURNAL OF UROLOGY, 1986, 135 (04): : 866 - 871
  • [29] P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF ANIMAL UVEAL MELANOMA
    KURHANEWICZ, J
    WINGUTH, SD
    CHAR, DH
    KALETA, S
    KINDYDEGNAN, N
    SWIFT, PS
    STAUFFER, PR
    WENDLAND, MF
    LOVATO, A
    CHANG, LH
    JAMES, TL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1990, 31 (09) : 1745 - 1753
  • [30] P-31 MAGNETIC-RESONANCE SPECTROSCOPY OF THE TEMPORAL LOBES IN SCHIZOPHRENIA
    CALABRESE, G
    DEICKEN, RF
    FEIN, G
    MERRIN, EL
    SCHOENFELD, F
    WEINER, MW
    BIOLOGICAL PSYCHIATRY, 1992, 32 (01) : 26 - 32